Professor David Matthew Altshuler is a clinical endocrinologist and human geneticist at the Broad Institute of Harvard and MIT. He is a Professor of Genetics and Medicine at Harvard Medical School, and in the Department of Molecular Biology, Center for Human Genetic Research, and the Diabetes Unit, all at Massachusetts General Hospital. He is one of four Founding Core Members of the Broad Institute, and serves as the Institute's Deputy Director, Chief Academic Officer, and Director of the Program in Medical and Population Genetics.Altshuler studies human genetic variation and its application to disease, using information from the Human Genome Project. He has co-led the SNP Consortium, International HapMap Project, and 1000 Genomes Project His own research focuses on the genetic basis of Type 2 Diabetes, and his laboratory has contributed to mapping dozens of gene variants that are associated with risk of Type 2 Diabetes, lipid levels, myocardial infarction, rheumatoid arthritis, lupus, prostate cancer, and other disorders.Altshuler received his Bachelor of Science from Massachusetts Institute of Technology, his Ph.D from Harvard University, and his M.D. from Harvard Medical School. He completed his internship, residency, and clinical fellowship training at Massachusetts General Hospital.Among his awards are election to the American Society for Clinical Investigation, the Association of American Physicians, and the Institute of Medicine. He is a member of the Board of Directors of the American Society of Human Genetics and of Vertex Pharmaceuticals. In 2011 he won the Curt Stern Award of the American Society of Human Genetics, and in 2012 the Outstanding Scientific Achievement Award of the American Diabetes Association.
$200,000
